Not Yet RecruitingPhase 1ACTRN12605000277640

Physician Preference/ Performance Evaluation of F.A.S.T.-LVG for the Temporary Occlusion of Blood Flow in Patients During Interventional Procedures in Saphenous Vein Grafts and Coronary Arteries

Sponsor

Genesis Medical Interventional, Inc.

Enrollment

60 participants

Start Date

Sep 1, 2005

Study Type

Interventional

Conditions

Prevention/reduction of release or movement of potentially embolic debris from the treatment area and aspiration of such debris prior to blood flow restoration.

Summary

Physician satisfaction with device performance in preventing blood clots/debris from traveling from treatment site to the heart or head.

Eligibility

Sex: Both males and femalesMin Age: 21 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying physician Preference/ Performance Evaluation of F.A.S.T.-LVG for the Temporary Occlusion of Blood Flow in Patients During Interventional Procedures in Saphenous Vein Grafts and Coronary Arteries. You may be eligible if you are adults aged 21 and older who patient with evidence of myocardial ischemia. People with no exclusion criteria may not be able to participate. Participation may involve medical tests, study visits, and follow-up appointments.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Temporary proximal occlusion of saphenous vein grafts and coronary arteries during standard intervetional procedures.

Locations(1)

United States of America

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000277640